RTP Mobile Logo

Thursday, May 17, 2018, Washington, DC, 6:00 PM – 8:30 PM

Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from Practice — A 6-Part CNE Symposia Series Held During the 43rd Annual ONS Congress

PART 4 — Non-Small Cell Lung Cancer

Event Details

Marriott Marquis Washington, DC
901 Massachusetts Ave NW
Washington, DC 20001
Hotel Phone: (202) 824-9200

Meeting Room:
Independence A-E (Meeting Level 4)
Schedule (EST):
5:30 PM – 6:00 PM
Registration and Dinner Buffet

6:00 PM – 8:30 PM
Educational Program
There is no registration fee for this event. Preregistration is highly recommended as seating and meal service are limited.

Jennifer Kapo, MD
Chief, Palliative Care Service
Yale New Haven Hospital
Associate Professor of Medicine
Department of Internal Medicine
Yale University School of Medicine
New Haven, Connecticut

Gregory J Riely, MD, PhD
Associate Attending
Memorial Sloan Kettering Cancer Center
New York, New York

Additional faculty to be announced
Neil Love, MD
Research To Practice
Miami, Florida
Meeting space has been assigned to provide a symposium supported by AstraZeneca Pharmaceuticals LP and Takeda Oncology during the Oncology Nursing Society’s (ONS) 43rd Annual Congress, May 16-20, 2018 in Washington, DC. The Oncology Nursing Society’s assignment of meeting space does not imply product endorsement.


Cases Presented Will Include Discussion of the Following Topics:

  • MODULE 1: Biomarker Analysis in Newly Diagnosed Non-Small Cell Lung Cancer (NSCLC); Long-Term Management of EGFR-Positive Disease
  • MODULE 2: Current and Emerging Treatment Algorithms for ALK- or ROS1-Positive Disease
  • MODULE 3: Management of NSCLC in Patients with BRAF and Other Potentially Targetable Mutations
  • MODULE 4: Clinical Approach to Patients with Metastatic NSCLC Without a Targetable Mutation
  • MODULE 5: Emerging and Investigational Approaches in the Treatment of Localized NSCLC

CE Information

Target Audience:
This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of non-small cell lung cancer (NSCLC).

Learning Objectives:
Upon completion of this activity, participants should be able to:

  • Communicate to patients with non-small cell lung cancer (NSCLC) the clinical relevance of tumor histology and commonly identified genetic abnormalities.
  • Use biomarkers, clinical characteristics and tumor histology to select individualized front-line and subsequent treatment approaches for patients with metastatic NSCLC.
  • Discuss the benefits and risks associated with evidence-based systemic treatments for metastatic NSCLC, including chemotherapeutic agents, targeted biologic therapies and immunotherapies.
  • Educate patients about the side effects associated with existing and recently approved therapies, and provide preventive strategies to reduce or ameliorate these toxicities.
  • Assess emerging research on the benefits of early palliative care for patients with metastatic NSCLC, and integrate this information as appropriate into patient consultations.
  • Recall ongoing trials of other investigational approaches and agents in NSCLC, and refer patients and obtain consent for study participation.
  • Identify opportunities to enhance the collaborative role of oncology nurses in the comprehensive biopsychosocial care of patients with NSCLC to optimize clinical and quality-of-life outcomes.
Accreditation Statement:
Research To Practice is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation Statements:
This educational activity for 2.5 contact hours is provided by Research To Practice.

This activity is awarded 2.5 ANCC pharmacotherapeutic contact hours.

To obtain a certificate of completion and receive credit for this event, nurses must sign in at the registration desk upon arrival, attend the entire activity and return a completed Educational Assessment and Credit Form upon exiting the activity.

ONC/ILNA Certification:
This activity will be submitted to the ONCC for ILNA verification.

Unlabeled/Unapproved Uses Notice:
There is no implied or real endorsement of any product by Research To Practice or the American Nurses Credentialing Center. Any off-label use as declared by the FDA will be identified.

Content Validation and Disclosures:
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CNE activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

Research To Practice staff and external reviewers — The scientific staff, planners, managers and reviewers for Research To Practice have no relevant conflicts of interest to disclose.

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP and Takeda Oncology.


Marriott Marquis Washington, DC
901 Massachusetts Ave NW
Washington, DC 20001
Hotel Phone: (202) 824-9200

Meeting Room: 
Independence A-E (Meeting Level 4)

The Marriott Marquis Washington, DC is the headquarters hotel for the 2018 ONS Congress and is within a short walking distance (0.2 miles) of the Walter E Washington Convention Center.



This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of non-small cell lung cancer (NSCLC).

There is no registration fee for this event. However, preregistration is highly recommended as seating is limited.

Registration for clinicians in practice

I am a practicing nurse or other healthcare provider involved in the treatment of cancer.

Registration for clinicians in practice »
Registration for other/industry professionals*

For all other professionals, we are unable to confirm seating at this time. If you would like to stand by for participation in this event, please provide your contact information. Should seats become available for the program, we will notify you.

Standby Registration for Other/Industry Professionals »

* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
To ensure seating, please check in at our onsite registration desk at least one half hour prior to the start of the meeting. We cannot guarantee seating after the start of the program.

Meal service will be provided to those who attend the program, based on availability.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future CME/CNE programs.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.